Therapeutic Goods Administration Performance Report - 2023-24
This report provides information about our regulatory performance for the 2023-24 financial year.
About the report
Each year we provide information about our regulatory performance through the TGA Performance Report. We measure our performance in line with Commonwealth’s Resource Management Guide 128 Regulator Performance 3 Best Practice Principles, as a platform for the strategic objectives and focus areas outlined in the TGA Business Plan. The principles are as follows:
- Continuous improvement and building trust
- Risk-based and data driven
- Collaboration and engagement.
Using these principles as a foundation, we have measured our performance against the strategic objectives and focus areas outlined in our 2023-24 TGA Business Plan. Our strategic objectives are as follows:
Improve public health outcomes through regulation
Actively engage with our stakeholders
Promote compliance with regulatory requirements
Innovate and continuously improve
We have outlined notable activities in this report, across 35 focus areas corresponding to the four strategic objectives. Each strategic objective has several performance indicators against which we report our activities.
Due to the breadth and volume of work, it is not possible to mention all activities and achievements during the 2023-24 financial year. We regularly provide updates on our activities and achievements through various external mechanisms including our website, email newsletters, social media, events, webinars and various stakeholder forums.
This report contains performance statistics in the appendices covering the period 1 July 2023 to 30 June 2024. These statistics are arranged into product themes and work programs and may include outcomes associated with key performance indicators and other performance targets.
Contents
- Message from the Deputy Secretary
- Our purpose
- Our vision
- Our strategic intent
- Our strategic objectives
- Structure of the report
- Strategic objective 1 - Improve public health outcomes through regulation
- Strategic objective 2 – Build trust by actively engaging with our stakeholders
- Strategic objective 3 – Promote and enforce compliance with regulatory requirements
- Strategic objective 4 – Innovate and continuously improve
- Appendices